The potential impact of comparative effectiveness research on U.S. health care expenditures

Demography

Volumn 47, Issue SUPPL.1, 2010, Pages

  Perlroth, Daniella J ^a   Goldman, Dana P ^b,c   Garber, Alan M ^a,d  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c RAND CORPORATION   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BRACHYTHERAPY; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; COST CONTROL; ECONOMICS; HEALTH CARE COST; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MIDDLE AGED; OBSERVATION; PATIENT SELECTION; PROSTATE TUMOR; PROSTATECTOMY; REGRESSION ANALYSIS; STATISTICAL MODEL; UNITED STATES; UTILIZATION REVIEW;

AGED; BRACHYTHERAPY; COMPARATIVE EFFECTIVENESS RESEARCH; COST CONTROL; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMETRIC; OBSERVATION; PATIENT SELECTION; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED; REGRESSION ANALYSIS; TECHNOLOGY, HIGH-COST; UNITED STATES;

EID: 79952265144     PISSN: 00703370     EISSN: 15337790     Source Type: Journal    
DOI: 10.1353/dem.2010.0004     Document Type: Article

References (33)

1. Agency for Healthcare Research and Quality. 2009. "EPC Evidence Reports." U.S. Department of Health and Human Services, Washington, DC.
2. American Cancer Society. 2009. "Cancer Facts & Figures 2009." Atlanta, GA: American Cancer Society.
3. Bill-Axelson, A., L. Holmberg, M. Ruutu, M. Haggman, S.O. Andersson, S. Bratell, A. Spangberg, C. Busch, S. Nordling, H. Garmo, J. Palmgren, H.O. Adami, B.J. Norlen, and J.E. Johansson. 2005. "Radical Prostatectomy Versus Watchful Waiting in Early Prostate Cancer." New England Journal of Medicine 352:1977-1984.
4. Charlson, M.E., P. Pompei, K.L. Ales, and C.R. MacKenzie. 1987. "A New Method of Classifying Prognostic Comorbidity in Longitudinal Studies: Development and Validation." Journal of Chronic Diseases 40:373-383.
5. Congressional Budget Office (CBO). 2007a. "The Long-Term Outlook for Health Care Spending." Publication No. 3085. CBO, Washington, DC.
6. Congressional Budget Office (CBO). 2007b. "Research on the Comparative Effectiveness of Medical Treatments: Issues and Options for an Expanded Federal Role." Publication No. 2975. CBO, Washington, DC.
7. Cutler, D.M. and M. McClellan. 2001. "Is Technological Change in Medicine Worth It?" Health Affairs 20(5):11-29.
8. Cutler, D.M., A.B. Rosen, and S. Vijan. 2006. "The Value of Medical Spending in the United States, 1960-2000." New England Journal of Medicine 355:920-27.
9. Executive Office of the President, Council of Economic Advisors. 2009. "The Economic Case for Health Care Reform." June 2009. Available online at http://www.whitehouse.gov/assets/documents/CEA_Health_Care_Report.pdf.
10. Garber, A.M. and D.O. Meltzer. 2009. "Setting Priorities for Comparative Effectiveness Research." Pp. 15-33 in Implementing Comparative Effectiveness Research: Priorities, Methods, and Impact. Washington, DC: Brookings Institution.
11. Geithner, T.F. 2009. "2009 Annual Report of the Boards of Trustees of the Federal Hospital Insurance Trust Fund and the Federal Supplementary Medical Insurance Trust Fund." Available online at http://www1.cms.gov/ReportsTrustFunds/downloads/tr2009.pdf.
12. Ghali, W.A., R.E. Hall, A.K. Rosen, A.S. Ash, and M.A. Moskowitz. 1996. "Searching for an Improved Clinical Comorbidity Index for Use With ICD-9-CM Administrative Data." Journal of Clinical Epidemiology 49:273-278.
13. Goldman, D.P., G.F. Joyce, J.J. Escarce, J.E. Pace, M.D. Solomon, M. Laouri, P.B. Landsman, and S.M. Teutsch. 2004. "Pharmacy Benefits and the Use of Drugs by the Chronically Ill." Journal of the American Medical Association 291:2344-2350.
14. Goldman, D.P., G.F. Joyce, and P. Karaca-Mandic. 2006. "Varying Pharmacy Benefits With Clinical Status: The Case of Cholesterol-Lowering Therapy." American Journal of Managed Care 12(1):21-28.
15. Goldman, D.P., B. Shang, J. Bhattacharya, A.M. Garber, M. Hurd, G.F. Joyce, D.N. Lakdawalla, C. Panis, and P.G. Shekelle. 2005. "Consequences of Health Trends and Medical Innovation for the Future Elderly." Health Affairs 24(Suppl. 2):W5R5-W5R17.
16. Hoffman, R.M., W.C. Hunt, F.D. Gilliland, R.A. Stephenson, and A.L. Potosky. 2003. "Patient Satisfaction With Treatment Decisions for Clinically Localized Prostate Carcinoma. Results From the Prostate Cancer Outcomes Study." Cancer 97:1653-62.
17. Institute of Medicine. 2009. "Initial National Priorities for Comparative Effectiveness Research." Washington, DC: The National Academies Press.
18. Iversen, P., P.O. Madsen, and D.K. Corle. 1995. "Radical Prostatectomy Versus Expectant Treatment for Early Carcinoma of the Prostate. Twenty-three year follow-up of a prospective randomized study." Scandinavian Journal of Urology and Nephrology Supplement 128:502-504.
19. Joyce, G.F., J.J. Escarce, M.D. Solomon, and D.P. Goldman. 2002. "Employer Drug Benefit Plans and Spending on Prescription Drugs." Journal of the American Medical Association 288: 1733-1739.
20. Joyce, G.F., D.P. Goldman, P. Karaca-Mandic, and G.D. Lawless. 2008. "Impact of Specialty Drugs on the Use of Other Medical Services." American Journal of Managed Care 14:821-828.
21. Joyce, G.F., D.P. Goldman, P. Karaca-Mandic, and Y. Zheng. 2007. "Pharmacy Benefit Caps and the Chronically Ill." Health Affairs 26:1333-1344.
22. McClellan, M., B.J. McNeil, and J.P. Newhouse. 1994. "Does More Intensive Treatment of Acute Myocardial Infarction in the Elderly Reduce Mortality? Analysis Using Instrumental Variables." Journal of the American Medical Association 272:859-66.
23. Murphy, K.M. and R.H. Topel. 2006. "The Value of Health and Longevity." Journal of Political Economy 114:871-904.
24. National Aeronautics and Space Administration (NASA). n.d. "Gross Domestic Product: Deflator Inflation Calculator." Washington, DC: NASA.
25. National Cancer Institute. 2008a. "Surveillance and Epidemiology End Results Stat Fact Sheets." U.S. National Institutes of Health, Bethesda, MD.
26. National Cancer Institute. 2008b. "Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence-SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2007 Sub (1973-2005 varying)-Linked To County Attributes-Total U.S., 1969-2005." Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, Bethesda, MD.
27. Newhouse, J.P. 1992. "Medical Care Costs: How Much Welfare Loss?" Journal of Economic Perspectives 6(3):3-21.
28. Paulson, D.F., G.H. Lin, W. Hinshaw, and S. Stephani. 1982. "Radical Surgery Versus Radiotherapy for Adenocarcinoma of the Prostate." Journal of Urology 128:502-504.
29. Rosenbaum, P.R. and D.B. Rubin. 1984. "Reducing Bias in Observational Studies Using Subclassification on the Propensity Score." Journal of the American Statistical Association 79:516-524.
30. Schoen, C., S. Guterman, A. Shih, J. Lau, S. Kasimow, A. Gauthier, and K. Davis. 2007. "Bending the Curve: Options for Achieving Savings and Improving Value in U.S. Health Spending." Report. The Commonwealth Fund, New York.
31. Shappley, W.V., III, S.A. Kenfield, J.L. Kasperzyk, W. Qiu, M.J. Stampfer, M.G. Sanda, and J.M. Chan. 2009. "Prospective Study of Determinants and Outcomes of Deferred Treatment or Watchful Waiting Among Men With Prostate Cancer in a Nationwide Cohort." Journal of Clinical Oncology 27:4980-4985.
32. Warren, J.L., K.R. Yabroff, A. Meekins, M. Topor, E.B. Lamont, and M.L. Brown. 2008. "Evaluation of Trends in the Cost of Initial Cancer Treatment." Journal of the National Cancer Institute 100:888-897.
33. Wilt, T.J., R. MacDonald, I. Rutks, T.A. Shamliyan, B.C. Taylor, and R.L. Kane. 2008. "Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer." Annals of Internal Medicine 148:435-448.